113 related articles for article (PubMed ID: 25012622)
1. Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke.
Folyovich A; Biro E; Orban C; Bajnok A; Vasarhelyi B; Toldi G
CNS Neurol Disord Drug Targets; 2014; 13(5):801-6. PubMed ID: 25012622
[TBL] [Abstract][Full Text] [Related]
2. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
[TBL] [Abstract][Full Text] [Related]
3. Calcium influx kinetics, and the features of potassium channels of peripheral lymphocytes in primary Sjögren's syndrome.
Legány N; Toldi G; Orbán C; Megyes N; Bajnok A; Balog A
Immunobiology; 2016 Nov; 221(11):1266-72. PubMed ID: 27346388
[TBL] [Abstract][Full Text] [Related]
4. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
[TBL] [Abstract][Full Text] [Related]
5. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
[TBL] [Abstract][Full Text] [Related]
7. The effects of Kv1.3 and IKCa1 channel inhibition on cytokine production and calcium influx of T lymphocytes in rheumatoid arthritis and ankylosing spondylitis.
Toldi G; Munoz L; Herrmann M; Schett G; Balog A
Immunol Res; 2016 Apr; 64(2):627-31. PubMed ID: 26280090
[TBL] [Abstract][Full Text] [Related]
8. Analysis by flow cytometry of calcium influx kinetics in peripheral lymphocytes of patients with rheumatoid arthritis.
Bajnok A; Kaposi A; Kovács L; Vásárhelyi B; Balog A; Toldi G
Cytometry A; 2013 Mar; 83(3):287-93. PubMed ID: 23335202
[TBL] [Abstract][Full Text] [Related]
9. Calcium Influx Kinetics and the Characteristics of Potassium Channels in Peripheral T Lymphocytes in Systemic Sclerosis.
Toldi G; Legány N; Ocsovszki I; Balog A
Pathobiology; 2020; 87(5):311-316. PubMed ID: 32911471
[TBL] [Abstract][Full Text] [Related]
10. Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.
Chimote AA; Hajdu P; Sfyris AM; Gleich BN; Wise-Draper T; Casper KA; Conforti L
Cancer Res; 2017 Jan; 77(1):53-61. PubMed ID: 27815390
[TBL] [Abstract][Full Text] [Related]
11. Impact of aging on calcium influx and potassium channel characteristics of T lymphocytes.
Kollár S; Berta L; Vásárhelyi ZE; Balog A; Vásárhelyi B; Rigó J; Toldi G
Oncotarget; 2015 May; 6(15):13750-6. PubMed ID: 25948778
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon β.
Toldi G; Folyovich A; Simon Z; Zsiga K; Kaposi A; Mészáros G; Tulassay T; Vásárhelyi B
J Neuroimmunol; 2011 Aug; 237(1-2):80-6. PubMed ID: 21764463
[TBL] [Abstract][Full Text] [Related]
14. Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders?
Vianna-Jorge R; Suarez-Kurtz G
BioDrugs; 2004; 18(5):329-41. PubMed ID: 15377175
[TBL] [Abstract][Full Text] [Related]
15. Altered activation of peripheral CD8+ T cells in pediatric Crohn's disease.
Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
Immunol Lett; 2017 May; 185():48-51. PubMed ID: 28300604
[TBL] [Abstract][Full Text] [Related]
16. [Kv1.3 potassium channel expression changes after CD4(+) and subsets CD28(null)/CD28(+)T cells activation in peripheral blood of patients with acute coronary syndrome].
Feng DY; Zhang CT; Ma YX; Zhou HL; Xu RD; Yang XW; Huang S; Ma J; Quan XQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):599-604. PubMed ID: 19961728
[TBL] [Abstract][Full Text] [Related]
17. Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic stroke.
Gao T; Raza SA; Ramesha S; Nwabueze NV; Tomkins AJ; Cheng L; Xiao H; Yepes M; Rangaraju S
J Neuroinflammation; 2019 Jun; 16(1):116. PubMed ID: 31153377
[TBL] [Abstract][Full Text] [Related]
18. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
Hansen LK
Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
[TBL] [Abstract][Full Text] [Related]
19. Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.
Nicolaou SA; Szigligeti P; Neumeier L; Lee SM; Duncan HJ; Kant SK; Mongey AB; Filipovich AH; Conforti L
J Immunol; 2007 Jul; 179(1):346-56. PubMed ID: 17579055
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
